> About Aceto > Court Supervised Sale

To Our Valued Customers, Suppliers and Partners

Aceto has entered into a 'stalking horse' agreement to sell its legacy chemicals business assets to New Mountain Capital. To facilitate the sales process, the company and its U.S. subsidiaries have filed voluntary petitions under Chapter 11 of the U.S. bankruptcy code. The company's foreign chemicals business subsidiaries are not included in the filing but will be included in the sale. In addition, the company intends to enter into a 'stalking horse' agreement for its subsidiary, Rising Pharmaceuticals.

During the sales processes, all day-to-day U.S. and international operations will continue as usual and without interruption.

Our relationships with our customers, suppliers and partners are vitally important to all of us at ACETO. We want to assure you that our dedicated staff are here to provide to you the same regulatory support, quality assurance and intimate knowledge of worldwide sources of supply and product applications that you have come to expect from us over many years, even decades in some cases.

Our commitment to serving you is unwavering, and we look forward to emerging from these sales processes and working with you for many years to come.

  • Information Hotline
    Toll Free within the United States and Canada 1-844-216-7718
  • International 1-347-761-3238

  • FAQs

  • Click here to view Court filings and information about claims processing

  • Case Overview


  • Filing Date: February 19, 2019

  • Court Location: U.S. Bankruptcy Court for the District of New Jersey (Newark)

  • top